China Resources Pharmaceutical Group (01093.HK): Injectable Paclitaxel (Albumin-bound) (II) approved for listing

The Wisdom Financial News App reports that Shiyao Group (01093.HK) has announced that the injection paclitaxel (albumin bound) developed by the group (II)(100mg) has been approved for market launch by the China National Medical Products Administration, making it the world's first albumin bound paclitaxel formulation.